Metabolism of the Insecticide Permethrin
NCT00572884 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2007-12-13
Summary
Military personnel are exposed to the insecticide permethrin when using the DOD Insect Repellent System. A urinary metabolite of permethrin that is in high abundance and is relatively stable may be an ideal biomarker of exposure to this pesticide. Monitoring such a biomarker can prevent over-exposure. The objectives are to identify the most abundant human urinary metabolite following dermal exposure; to utilize this information to develop rapid laboratory-based and field portable methods to monitor the degree of an individual's exposure to permethrin.
Conditions
- Pharmacokinetics
- Metabolism
Interventions
- OTHER
-
permethrin insecticide
25 mg neat carbon-14 labelled permethrin applied dermally in isopropyl alcohol, once for 8 hours containing 1 microcurie of carbon-14
Sponsors & Collaborators
-
U.S. Army Medical Research and Development Command
collaborator FED -
University of California, Davis
lead OTHER
Principal Investigators
-
Bruce D Hammock, PhD · University of California, Davis
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-02-28
- Completion
- 2007-11-30
Countries
- United States
Study Locations
More Related Trials
-
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
NCT06309394 ·Status: COMPLETED ·Phase: PHASE1
-
AN OPEN-LABEL, ACUTE CLINICAL TRIAL TO ASSESS THE LEVEL OF KETONE PRODUCTION FOLLOWING CONSUMPTION OF AVELA™ (R)-1,3-BUTANEDIOL IN AN ADULT POPULATION
NCT05384106 ·Status: UNKNOWN ·Phase: NA
-
13C-Pyruvate Breath Test
NCT01807702 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects
NCT01048203 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants
NCT05284890 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MK-8527 in Healthy Adult Participants (MK-8527-013)
NCT06826989 ·Status: COMPLETED ·Phase: PHASE1
-
Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers
NCT02963324 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
NCT05981963 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male Subjects
NCT02059590 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)
NCT06295796 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)
NCT06658626 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
NCT00868361 ·Status: TERMINATED ·Phase: PHASE1
-
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB086550
NCT05101369 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of [14C]-GDC-0810 After Single Oral Administration in Healthy Female Participants
NCT02802670 ·Status: COMPLETED ·Phase: PHASE1
-
Kinetic Time Courses of Bisphenol-S in Volunteers
NCT03340168 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects
NCT07027982 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability and Pharmacokinetic Study of GDC-0032 in Healthy Volunteers
NCT01967966 ·Status: COMPLETED ·Phase: PHASE1
-
A Study On Human Mass Balance And Biotransformation
NCT05040113 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers
NCT01336387 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants
NCT05409157 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
NCT02126514 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Detect Radioactivity of [14C]-OPC-167832 in Urine and Feces in Healthy Men
NCT07314320 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects
NCT01406132 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects
NCT02595203 ·Status: COMPLETED ·Phase: PHASE1
-
Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine
NCT01392313 ·Status: WITHDRAWN ·Phase: NA